S 1097 · Interagency Patent Coordination and Improvement Act of 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
- Introduced
- Mar 24, 2025
- Latest action
- Apr 10, 2025
- Sponsor
- Sen. Richard J. Durbin [D-IL]
- Policy area
- Commerce
- Cosponsors
- 4
Summary
Interagency Patent Coordination and Improvement Act of 2025 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Recent actions
- Apr 10, 2025 Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
- Apr 10, 2025 Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- Apr 10, 2025 Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- Apr 3, 2025 Committee on the Judiciary. Ordered to be reported with amendments favorably.
- Mar 24, 2025 Read twice and referred to the Committee on the Judiciary. (text: CR S1804-1805)
- Mar 24, 2025 Introduced in Senate
Votes
No recorded votes are available for this bill.